Update on Neurological Manifestations of HTLV-1 Infection.

Area of Science:

• Neurology
• Virology
• Immunology

Background:

• Human T cell lymphotropic virus type 1 (HTLV-1) infects millions globally.
• HTLV-1 is linked to adult T cell leukemia/lymphoma (ATLL) and various neurological syndromes.
• HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a progressive myelopathy caused by HTLV-1.

Purpose of the Study:

• To summarize the clinical and neuropathological features of HTLV-1-associated neurological syndromes.
• To discuss the current understanding of HTLV-1 neuropathogenesis.
• To review the symptomatic nature of current HAM/TSP therapies.

Main Methods:

• Literature review of HTLV-1 and associated neurological conditions.
• Analysis of clinical presentations and neuropathological findings in HAM/TSP.
• Discussion of current therapeutic approaches for HAM/TSP.

Main Results:

• HAM/TSP presents as chronic progressive spastic paraparesis with neurogenic bladder.
• Neuropathology involves lymphocytic infiltration followed by gliosis and scarring in the thoracic spinal cord.
• HTLV-1 infection triggers a spectrum of neurological disorders beyond HAM/TSP.

Conclusions:

• HTLV-1 causes a range of debilitating neurological conditions, with HAM/TSP being a prominent example.
• The neuropathogenesis of HTLV-1 remains incompletely understood.
• Effective disease-modifying therapies for HAM/TSP are currently lacking, with treatment focusing on symptom management.